Main Menu

Centre for Global Oncology external research activities

Ongoing projects across the ICR are responding to the need to engage in cancer research across low and middle income countries.

  • Genetic predisposition to prostate cancer in the PRACTICAL consortium: increasing participation in developing countries (Ros Eeles; HEFCE; 2017-2018)
  • How do the molecular landscapes of pre-menopausal triple-negative breast cancers differ between Indian and Western populations? (Maggie Cheang and Anguraj Sadanandam; Newton Fund through HEFCE; 2017-2018)
  • A comparison of unmet needs in women following primary breast cancer treatment in two African countries and the UK: the feasibility of implementing holistic needs assessments (HNA), care plans and treatment summaries in Africa (Susannah Stanway; HEFCE; 2017-2018)
  • Responding to unmet need after cancer treatment: Development and evaluation of a competency framework for cancer nurses and peer support advocates in Africa (Susannah Stanway; Research England; 2018-2019)
  • Clinical and molecular landscapes of triple-negative breast cancer in India and application to improved treatment decisions (Anguraj Sadanandam; Research England; 2018-2019)
  • Characterisation of epidermal growth factor receptor inhibitor resistance and new therapies for lung cancer in Asia (Paul Huang; Research England; 2018-2019)
  • Genetic predisposition to prostate cancer in the PRACTICAL consortium: increasing infrastructure and participation in developing countries (Ros Eeles; Research England; 2019-2020)
  • Building knowledge and capacity within palliative care in a new cancer centre in the Eastern region of Democratic Republic of Congo, Africa (Susannah Stanway; Research England; 2019-2020)
  • Understanding clinico-pathological and molecular profiles of Indian colorectal cancer with respect to advanced disease and treatment challenges (Anguraj Sadanandam; Research England; 2019-2020)
  • CCR5115 KORTUC phase II - Randomised phase II trial testing efficacy of intra-tumoural hydrogen peroxide as a radiation sensitiser in patients with locally advanced/recurrent breast cancer (Navita Somaiah; Research England; 2019-2020).

Global oncology team

  • Dr Sadanandam is a Founding Member of Indian Cancer Genome Atlas (ICGA) – an initiative to India’s version of The Cancer Genome Atlas. 

In this section

External research activities